Apparatus and methods for treating sleep apnea

ABSTRACT

An apparatus and method for treating sleep apnea and/or snoring is provided. The apparatus includes an appliance sized and structured to be placed in the pharyngeal region of a human or animal and being effective in treating sleep apnea and/or snoring, for example in maintaining openness of an oropharyngeal region of a human or animal during natural sleep, advantageously while not interfering with normal functioning of the epiglottis. The appliance may be made of a super elastic material, for example, Nitinol, and may be submucosally implanted in the pharyngeal walls.

RELATED APPLICATIONS

This application is a continuation of co-pending application Ser. No.10/541,255, filed Mar. 27, 2006, which is a continuation-in-part of U.S.patent application Ser. No. 10/624,915 filed on Jul. 22, 2003 whichclaims the benefit of U.S. provisional application Ser. No. 60/436,945filed on Dec. 30, 2002, and U.S. provisional application Ser. No.60/437,058 filed on Dec. 30, 2002, the disclosure of each of which isincorporated in its entirety herein by this specific reference.

BACKGROUND OF THE INVENTION

The present invention generally relates to apparatus and methods fortreating sleep apnea and/or related breathing disorders, and morespecifically relates to apparatus for placement in the oropharyngealregion of a human or animal and methods using such apparatus fortreating sleep apnea and/or snoring.

Sleep apnea is a sleep-related breathing disorder that is thought toaffect between 1-10% of the adult population. Recent epidemiologic dataindicate that 2% of women and 4% of men between the ages of 30 and 60years meet the minimum diagnostic criteria for sleep apnea syndrome,representing more than 10 million individuals in the United States. Itis a disorder with significant morbidity and mortality, contributing toincreased risk of hypertension, cardiac arrhythmias, stroke, andcardiovascular death. Another common sleep-related breathing disorder issnoring, which may be associated with or independent of sleep apnea.

The present invention has been developed to aid in the treatment ofsnoring and/or the various degrees of hypopnea and apnea that occur dueto pathological disturbances in the sleep process. One of the mainreasons of the sleep disturbance is the relaxation of the tongue andpharyngeal walls to varying degrees during the several stages of sleep.When fully awake, these tissues have normal tone as air passes in andout of the lungs during respiration. However, during sleep, themusculature supporting these tissues relaxes. As air is inspired, thetongue and posterior walls of the pharynx collapse, causing snoring ormore seriously, causing partial or complete obstruction of the airway.

Obstructive sleep apnea occurs due to a collapse of soft tissue withinthe upper airway during sleep. The ongoing force of inspiration servesto generate increasingly negative pressure within the pharynx, causingfurther collapse. The lack of respiration results in inadequate bloodoxygenation, and rising carbon dioxide levels. The cardiovascularresponse produces an increase in the blood pressure and pulse. Cardiacarrhythmias often occur. The carbon dioxide increase and oxygendesaturation triggers a transition to a lighter sleep stage, usuallywithout wakefulness. This transition brings a return to tonicity of themuscles of the upper airway, allowing normal breathing to resume. Theperson then returns to deeper stages of sleep and the process isrepeated. The disease is quantified in terms of respiratory disturbancesper hour. Mild disease begins at ten per hour, and it is not uncommon tofind patients with indices of about one hundred or more.

Not surprisingly, sleep is extremely fragmented and of poor quality inpersons suffering from sleep apnea. As a result, such persons typicallyfeel tired upon wakening and may fall asleep at inappropriate timesduring the day. All aspects of quality of life, from physical andemotional health, to social functioning are impaired by obstructivesleep apnea.

Continuous Positive Airway Pressure (“CPAP”), disclosed for example inU.S. Pat. No. 5,065,756, is a popular non-surgical treatment forpatients suffering from sleep apnea. The disclosure of this patent isincorporated in its entirety herein by reference. CPAP is administeredby means of a mechanical unit that delivers pressurized room air to thenasal passage, or airway, through a nose mask that is worn by thepatient during sleep. Pressurized air enters from the CPAP unit throughthe nose when a person is sleeping, and opens the airway from the insidealmost as if the air were an internal splint. The correct pressure forthe individual is determined in a sleep laboratory. If the nasal airwaywill admit the flow of air, CPAP has in many cases offered immediaterelief. Unfortunately however, compliance with, and long-term acceptanceof this treatment are generally poor. Studies have shown that between20% and 50% of patients fail to use nasal CPAP as prescribed. Problemsassociated with CPAP include excessive dryness of the mouth and throat,mucous congestion, sinusitis, and rhinorrhea. Breathing against positiveair pressure is also discomforting to many patients.

Other non-surgical treatments for sleep apnea include the use of tongueretaining devices and other oral appliances that hold and/or pull thetongue or jaw in a forward position to open the airway by reducingcollapse of the soft palate and/or tongue. These devices also sufferfrom poor compliance rates, and are usually associated with degenerativechanges in the temporomandibular joint.

Surgical procedures have been proposed and practiced for the treatmentof moderate to severe sleep apnea. Uvulopalatopharyngoplasty (“UPPP”) isa surgical procedure used to treat obstructive sleep apnea. In UPPP, anyremaining tonsillar tissue and a portion of soft palate is removed. Theprocedure increases the width of the airway at the throat opening.However, UPPP does not address apnea caused by obstructions deeper inthe throat and airway, for example, apnea resulting from collapse oftissue near the base of tongue or in the oropharyngeal region of theairway.

LAUP, or Laser-Assisted Uvulopalatoplasty, is a modification of theabove-mentioned technique, but has not proven particularly useful forsleep apnea. These surgical techniques are extremely invasive, requiringgeneral anesthesia, and a prolonged, painful recovery.

Radio frequency tissue ablation (RFTA) with the trade name“Somnoplasty,” has been used to shrink the soft palate, uvula and reducetongue volume in the treatment of snoring and obstructive sleep apnea.Somnoplasty utilizes a radiofrequency tool that generates heat to createcoagulative lesions at specific locations within the upper airway. Thelesions created by the procedure are naturally resorbed in approximatelythree to eight weeks, reducing excess tissue volume and increasing theairway opening. Like UPPP and LAUP, more than one session is typicallyrequired and it does not address sleep apnea resulting from tissuesdeeper in the throat than the upper airway.

Another area of surgical interest lies in techniques designed to pullthe tongue anteriorly. The most recent such surgical system designed totreat snoring (as well as obstructive sleep apnea) was approved by theFDA in February 1998. Known as the tongue suspension procedure (with thetrade name Repose), it is intended to pull the tongue forward, therebykeeping the tongue from falling into the airway during sleep. The systemutilizes a bone screw inserted into the mandible. The screw attaches toa non-absorbable suture which travels the length of the tongue and back.Similarly, the hyoid bone can be drawn anteriorly with two distinctscrews, also attached to the mandible.

Techniques have also been developed for treating, specifically, thecondition of snoring. Conrad et al., U.S. Pat. No. 6,250,307 discloses amethod for treating snoring of a patient, which includes embedding animplant into a soft palate of a patient in order to alter a dynamicresponse of a soft palate to airflow. The methods of Conrad et al. arespecifically designed to reduce the audibility of snoring but do notaddress the more serious condition of sleep apnea.

These conventional devices and treatments continue to suffer poor curerates. The failures lie in their inability to maintain patency in theretropalatal region and retroglossal region (the caudal margin of thesoft palate to the base of the epiglottis). The poor success ratescombined with high morbidity, contribute to an ongoing need for moreeffective treatments for sleep apnea and/or snoring.

SUMMARY OF THE INVENTION

Accordingly, the present invention provides apparatus and methodseffective to treat, for example, to substantially eliminate or at leastreduce the occurrence of, sleep apnea and/or snoring, meaning to includesnoring and/or other sleep-related breathing disorders. The apparatusand methods are relatively straightforward to structure and use, areminimally invasive and provide substantial benefits over conventionaltechniques in controlling sleep apnea and/or snoring.

In one broad aspect, the present invention provides apparatus comprisingan appliance sized and structured to be permanently (that is, for longterm usage or for a relatively long time, such as at least about 1 weekor about 1 month, preferably at least about 6 months, more preferably atleast about 1 year, even more preferably about 5 years or longer) ortemporarily implanted or placed in an oropharyngeal region of a human oranimal

The present apparatus may comprise any material or materials suitablefor placement in the pharyngeal region which are effective to stiffen,reinforce and/or strengthen tissues of the region in order to providesupport to these tissues against collapse such that a patient canbreathe more effectively than the patient would breathe without thematerial or materials placed in the region.

In one embodiment of the invention, the apparatus generally comprise anappliance sized and structured to be placed in a given position in theoropharyngeal region, other than to facilitate a surgical procedure, andto be effective, when placed in the given position, to treat sleep apneaand/or snoring in a human and or animal (hereinafter, sometimes“patient”). In addition, the appliance is structured to be effective,when so placed, to provide at least one additional benefit relative to adifferent device that is sized and structured for placement in aposition in the patient other than in the given position in theoropharyngeal region. Preferably, the appliance is structured to providean enhanced compliance with normal, healthy functioning of theoropharyngeal region of a patient relative to such a different device,for example, a stent that is not specifically structured to be utilizedfor treatment of sleep apnea. For example, the apparatus is structuredto have an enhanced, relative to such a different device, ability to betolerated, preferably comfortably tolerated, by the human or animalwhile the apparatus is in the given position in the oropharyngealregion, such as when the human or animal is awake or is naturallysleeping.

The appliance of the present invention is advantageously structured tohave an enhanced, relative to such a different device, ability toprovide support against collapse of the oropharyngeal region duringnatural sleep, as well as to allow proper closure of an airway in theoropharyngeal region during swallowing.

Preferably, the appliance is sized and structured so that, when soplaced in the given position in the oropharyngeal region, the applianceis located substantially entirely within the pharyngeal regionincluding, preferably, the oropharyngeal region. The apparatus is sizedand structured to be temporarily placed in the given position or to beplaced in the given position on a relatively long term basis forexample, as described elsewhere herein. In addition, the appliance ispreferably structured to resist migration within the oropharyngealregion or outside the oropharyngeal region.

In one embodiment of the invention, the appliance comprises asubstantially flat or planar member, when located outside the body in aresting or at rest position, including spaced apart end portions and abody portion joining the end portions. In this embodiment of theinvention, the apparatus preferably is designed such that when theapparatus is appropriately positioned in the given position, theappliance takes on a curved configuration with end portions bearingagainst and supporting against collapse, the lateral walls of theoropharyngeal region. The appliance may be sized and structured suchthat when the apparatus is appropriately placed in the given position,the end portions are spaced apart anteriorly of the posterior wall ofthe oropharyngeal region, for example, by a portion of the anterior wallof the oropharyngeal region. Preferably, the appliance expands to forman effective diameter of about 32 mm or greater in order to adequatelyexpand to fill the oropharyngeal region.

In some embodiments of the invention, the apparatus may be structured tofacilitate removal thereof from the oropharyngeal region. For example,the apparatus may be structured such that when the apparatus is in otherthan the deployed configuration, for example, when the apparatus islocated outside an oropharyngeal region of a human or animal or outsidethe body of the human or animal in a resting position, the appliancecomprises a member that has a flexibility and resiliency that allows theappliance to be folded, rolled or coiled to take on a relatively smallerradius for facilitating insertion and/or removal thereof into or fromthe oropharyngeal region, for example, through the mouth or oral cavityof the patient. When introduced and released into the pharyngeal region,the appliance unfolds, unrolls or uncoils, and provides pressure againstone or more portions of the pharyngeal region, providing support theretoand maintaining or achieving patency of the pharyngeal region, forexample, whether the patient is awake or is naturally sleeping.

The appliance is preferably sized and structured to allow substantiallynatural functioning of the oropharyngeal region and the epiglottis whenthe appliance is located in the given position in the pharyngeal regionof the patient.

It will become apparent that various configurations of the apparatus arepossible to achieve one or more of the benefits of the present inventionin treating, e.g. controlling, sleep apnea and/or snoring, and it is tobe appreciated that each of such various configurations, for example,the herein disclosed various configurations and modifications thereof,are considered to be within the scope of the present invention. Suchconfigurations include, but are not limited to, an appliance having asubstantially elliptical configuration, a substantially circularconfiguration, a substantially rectangular configuration, asubstantially cylindrical configuration, a substantially linearconfiguration, a substantially cross-shaped configuration, asubstantially C-shaped configuration, a substantially cuff shapedconfiguration, a substantially coil shaped configuration and the likeconfigurations and combinations thereof. For example, in a more specificembodiment of the invention, the appliance comprises, in a rest positionoutside the body of a human or animal a substantially, flat, flexible,elliptical member having rounded end portions, a length defined betweenthe end portions, and a body portion comprising a plurality of spacedapart struts extending along at least a substantial portion of thelength between the end portions.

Preferably, the appliance, when located in the oropharyngeal region, hasa resiliency and flexibility, for example, resiliency and/or flexibilityin at least one direction or at least two different directions or atleast three different directions, that enables the appliance to providean appropriate amount of support and reinforcement to oropharyngealtissues during natural sleep, while enabling substantially normalfunctioning of the oropharyngeal region and the epiglottis, for example,during swallowing.

In some embodiments of the invention, the apparatus comprises anappliance sized and structured to be placed within the pharyngeal regionof the patient and, when so placed, having an intrinsic ability tomaintain patency of the pharyngeal region during natural sleep of thepatient.

For example, the appliance may be structured to cause a reduced fibroticreaction when placed in the pharyngeal region relative to a similarappliance that is structured from materials that will cause a fibroticresponse, for example relative to a similar appliance that is made ofpolyester.

In some embodiments of the invention, the appliance having saidintrinsic ability to maintain patency is structured to have smooth,radiused edges and smooth surfaces, for example in order to inhibit afibrotic reaction of tissues when the appliance is placed in thepharyngeal region.

In some embodiments of the invention, the appliance is structured tocause the substantially no fibrotic reaction when placed in thepharyngeal region.

The appliance preferably comprises an elastic material. More preferably,the appliance comprises a super-elastic material. A number of suitableelastic and super-elastic materials are well known and can be employedin the present apparatus. One particularly useful material is metallicmaterial, or metal, for example a super-elastic metal such as a nickeltitanium alloy, known as Nitinol. The appliance preferably has a hoopstrength effective to support the oropharyngeal region against collapseduring natural sleep. More preferably, the appliance has a hoop strengthin a range of at least about 5 cm water to about 400 cm water orgreater.

The apparatus advantageously comprises an appliance sized and structuredto be placed in a position in the oropharyngeal region in proximity tothe epiglottis, other than to facilitate a surgical procedure, effectivein treating sleep apnea and/or snoring. The appliance is sized andstructured to substantially entirely fit within the oropharyngeal regionwhen placed in position. A portion of the device may also be consideredto extend above the oropharyngeal region along the posterior portion ofthe pharynx.

In another broad aspect of the invention, the apparatus for treatingsleep apnea and/or snoring comprises an element placed within theoropharyngeal region that is effective, when so placed, to stiffen,reinforce and/or strengthen tissues within the oropharyngeal region inorder to support these tissues against collapse and allow substantiallynormal breathing during sleep.

For example, the element may comprise at least one strip of materialthat is structured to be placed within the walls of the pharyngealregion. For example, the element may comprise multiple strips ofmaterial, such as multiple strips of metal, that are structured andsuitable to be implanted within the oropharyngeal tissues, for example,beneath the mucosal tissue. In other words, such strips of material arestructured and are suitable for submucosal placement within the walls ofthe pharyngeal region. To illustrate this feature of the invention, theelement may comprise multiple strips of the same or different sizesand/or dimensions that are suitable for implantation in a spaced apartarrangement. For example, the multiple strips may be implanted in agenerally horizontal fashion, that is, with the patient in the supineposition, generally parallel to the length or longitudinal axis of thepatient's body.

In a related aspect of the invention, a method for treating sleep apneaand/or snoring comprises the steps of securing one or more elements tothe pharyngeal region and allowing the elements to provide an openingforce against the pharyngeal walls, such opening force being sufficientto reinforce the walls against collapse during natural sleep whileallowing substantially normal functioning of the oropharyngeal region.

Preferably the method comprises placing at least partially submucosally,within the pharyngeal region of a patient, an appliance effective, whenso placed, to maintain patency of the pharyngeal region.

Preferably, the step of placing comprises placing the apparatussubstantially entirely submucosally, preferably in the oropharyngealregion.

The apparatus, in accordance with an especially advantageous embodimentof the invention, is sized to be placed, at least partially,circumscribing an interior hollow passage defined by the pharyngealregion, for example the oropharyngeal region. In a related aspect of theinvention, the appliance is sized to be placed circumscribing, at leastonce, the interior hollow passage defined by the pharyngeal region.

In another embodiment of the invention, the element may comprise anelement that provides a magnetic opening force against collapsingpharyngeal, for example, oropharyngeal, tissues. For example, theelement may comprise an appliance, such as described and shown elsewhereherein, that is at least partially magnetized. More specifically, theelement may comprise two or more magnetic elements having like polesfacing one another, to create a magnetic field that can be utilized toprovide a useful opening force to the pharyngeal, for example,oropharyngeal, region.

In another embodiment of the invention, the apparatus comprises anelement that includes a transverse portion sized and structured toprovide an opening force to the pharyngeal region and at least onelongitudinal portion depending from the transverse portion, for examplefrom an end of the transverse portion. The transverse portion may have asubstantially bow or curved shape, or may be straight and planar. Thelongitudinal portion is structured to be placed substantiallysubmucosally within the pharyngeal region, for example, extendingdownward from the transverse portion and aligned along a longitudinalaxis of the pharyngeal region.

The at least one longitudinal portion may comprise two or morelongitudinal portions, depending from and spaced apart by the transverseportion. In one aspect of the invention, the longitudinal portionscomprise two longitudinal portions depending from each end of thetransverse portion. In this embodiment of the invention, the element hasa substantially U-shaped configuration.

In yet another embodiment of the invention, the appliance includes atleast one element having a substantially bow shaped, substantiallylinear configuration and being sized and structured to be placed atleast partially submucosally within the walls of the pharyngeal regionin a position transverse to a longitudinal axis of the pharyngealregion. The at least one element may comprise a plurality of saidelements having substantially bow shaped, substantially linearconfigurations, such that a plurality of the elements may be placed atspaced apart intervals within the walls of the pharyngeal region.

In some embodiments of the invention, the apparatus comprises acomponent which has a length and a thickness smaller than the lengthand, which when placed into the pharyngeal region, extends alongitudinal distance, along the pharyngeal region, a distance furtherthan or greater than the thickness of the component.

Methods for treating sleep apnea and/or snoring in a human or an animalhaving an oropharyngeal region are provided. In one aspect of theinvention, the methods generally comprise providing an appliance, suchas described elsewhere herein, in the oropharyngeal region of the humanor animal The appliance, located in the oropharyngeal region, iseffective in treating sleep apnea and/or snoring during natural sleep ofthe human or animal

In one embodiment, the step of providing includes placing an appliancein the oropharyngeal region that is effective in maintaining patency ofthe oropharyngeal region during natural sleep of the human or animalPreferably, the appliance is effective in maintaining patency withoutcausing substantial interference with one or more natural functions ofthe oropharyngeal region or the epiglottis. For example, the appliancemay be structured, when placed in the pharyngeal region, to be effectiveto support the tissues of the oropharyngeal region against collapsewhile allowing the oropharyngeal region to close and/or otherwisefunction consistent with normal swallowing. The apparatus is designed sothat, when the appliance is placed in the pharyngeal region it iseffective in supporting and holding the lateral walls of theoropharyngeal region in an open position, and/or in supporting andholding the tongue of the patient in a forward position, for example,during natural sleep of the patient.

In yet another embodiment of the invention, a method is provided formaintaining patency of a pharyngeal region of a human or an animalduring natural sleep. The method generally comprises the steps ofproviding a member in a substantially flat or precurved configuration,the member having a body portion and end portions spaced apart by thebody portions, and implanting the member, at least partiallysubmucosally, within the pharyngeal region.

Advantageously, the member is effective to provide a substantiallyconstant force against at least a portion of each of a right and leftlateral wall of the pharyngeal region.

For example, the step of implanting comprises implanting the member intopharyngeal region such that the member is substantially entirelysubmucosally implanted therein.

In yet another embodiment of the invention, a method for maintainingpatency of a pharyngeal region of a human or animal during natural sleepand for purposes other than surgery is provided wherein, the methodgenerally comprises the steps implanting an appliance that is structuredto intrinsically cause or maintain patency of the pharyngeal region whenimplanted therein. This is distinguished from a method of the presentinvention for treating a patient which comprises a step of causing atissue reaction of a pharyngeal region of the patient, said tissuereaction being effective in at least one of strengthening and stiffeninglateral walls of the pharyngeal region. For example, in an alternativeembodiment of the invention, the method comprises strengthening thewalls of the oropharyngeal region by, for example, causing a tissuereaction, for example, by applying an active agent to the walls of thepharyngeal region or, for example, placing at least one member into thelateral walls to cause a tissue reaction.

Preferably, the step of providing may include inserting the applianceinto the oropharyngeal region, for example through the mouth or oralcavity of the patient, or alternatively, through the nasal cavity of thepatient, while the appliance is in a first configuration and,thereafter, allowing the appliance to reconfigure to a secondconfiguration within the oropharyngeal region.

In yet another aspect of the invention, a method for treating sleepapnea and/or snoring may comprise causing a tissue reaction in anoropharyngeal region of a patient. Such tissue reaction is effected tocause sufficient stiffening and/or strengthening of targetedoropharyngeal tissues in order to substantially reduce the occurrence ofcollapse of those tissues during natural sleep of the patient.

For example, the step of causing a tissue reaction may comprise one ofinjecting a suitable agent into the tissues, applying wave energy to thetissues and/or causing mechanical irritation to the tissues in order toprovoke a strengthening response.

Each and every feature described herein, and each and every combinationof two or more of such features, is included within the scope of thepresent invention provided that the features included in such acombination are not mutually inconsistent.

These and other aspects of the present invention are apparent in thefollowing detailed description and claims, particularly when consideredin conjunction with the accompanying drawings in which like parts bearlike reference numerals.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a side view of an apparatus of the present inventionpositioned in an oropharyngeal region of a patient (shown incross-section for clarity).

FIG. 2 shows a perspective view of an embodiment of the inventioncomprising a substantially solid walled cylindrical appliance.

FIG. 3 shows a perspective view of another embodiment of the inventioncomprising a substantially mesh walled cylindrical appliance.

FIG. 4 shows a perspective view of an additional embodiment of theinvention similar to the apparatus shown in FIG. 2, and including arecessed portion for accommodating an epiglottis of a patient.

FIG. 5 shows a perspective view of yet another embodiment of theinvention including an extended portion.

FIG. 6 shows a perspective view of a further embodiment of the inventioncomprising a coiled appliance.

FIGS. 7, 8, and 9 show, in perspective view, various other embodimentsof the invention comprising substantially cuff-shaped appliances ofdifferent proportions to accommodate different patient needs.

FIG. 10 shows a perspective view of still another embodiment of theinvention comprising a substantially cuff shaped embodiment comprising amesh material.

FIG. 11 a perspective view shows a yet further embodiment of theinvention comprising a substantially solid C-shaped appliance havingapertures for allowing tissue ingrowth.

FIG. 12 shows a perspective view of an alternate embodiment of theinvention that comprises a flat flexible member including spaced apartstruts extending between rounded end portions.

FIGS. 13-16 show, in plan view, other alternate embodiments of theinvention similar to the embodiment shown in FIG. 12.

FIGS. 17-21 show, in plan view, various other alternative embodiments ofthe invention comprising a single loop element.

FIGS. 22-23 show, in plan view, yet other embodiments of the invention.

FIG. 24 shows a side view of a preferred embodiment of the invention inwhich the apparatus comprises an elongated element structured to be atleast partially submucosally implanted in the pharyngeal region of apatient.

FIG. 24 a shows an alternative cross section of an embodiment of theinvention similar to the embodiment shown in FIG. 24, comprisingmultiple, spaced apart elongated elements at least partiallysubmucosally implanted within the oropharyngeal region of a patient.

FIG. 25 shows a plan view of the embodiment of the invention shown inFIG. 24.

FIGS. 25 a and 25 b show cross-sectional views of alternativecross-sectional shapes of the embodiment of the invention shown in FIG.25.

FIGS. 26-28 each show a simplified view of the oropharyngeal regionhaving various apparatus of the invention submucosally implantedtherein.

FIG. 29 shows a simplified perspective view of another embodiment of theinvention including an element having a transverse portion and twosubstantially longitudinal portions depending from, and spaced apart by,the transverse portion.

FIG. 29A shows a simplified perspective view of an embodiment of theinvention similar to the embodiment shown in FIG. 29, in which thetransverse portion is sloped downwardly with respect to the longitudinalportions.

FIG. 30 shows another embodiment of the invention similar to theembodiment shown in FIG. 29, wherein the apparatus includes an appliancehaving a substantially planar, substantially U-shaped configuration.

FIG. 30A shows a magnified view of a portion of the apparatuscircumscribed by line A of FIG. 30.

FIG. 30B shows a magnified view of a portion of the apparatuscircumscribed by line B of FIG. 30.

FIG. 30C shows a side view of the apparatus of FIG. 30.

FIG. 31 shows a plan view of another embodiment of the inventioncomprising a substantially bow shaped element.

FIG. 31A shows a side view of the embodiment of the invention shown inFIG. 31.

FIG. 32 shows a plan view of yet another embodiment of the inventionsimilar to the embodiment shown in FIG. 31 but having a different radiusof curvature.

FIG. 32A shows a side view of the embodiment of the invention shown inFIG. 32.

DETAILED DESCRIPTION OF THE INVENTION

In a broad aspect of the invention, the apparatus generally comprise anappliance sized and structured to be placed in a given position in anoropharyngeal region of a human or animal patient, other than tofacilitate a surgical procedure on said patient, and being effective intreating sleep apnea and/or snoring of said patient. The appliance isfurther effective, when so placed in the given position, to provide atleast one additional benefit or advantage relative to a device sized andstructured for placement in a different position in a human or animalwherein a “different position” is defined as a position other than thegiven position.

Incorporated herein by this specific reference is the entire disclosureof each of the following patents:

Fraser et al. U.S. Pat. No. 5,571,135, Turnland U.S. Pat. No. 5,360,401,Winston et al. U.S. Pat. No. 5,306,294, Heyn et al. U.S. Pat. No.5,201,757, Burton et al. U.S. Pat. No. 5,078,720, Termin et al. U.S.Pat. No. 5,071,407, Porter U.S. Pat. No. 5,064,435, Wallsten et al. U.S.Pat. No. 5,061,275, Burton et al. U.S. Pat. No. 5,026,377, Savin et al.U.S. Pat. No. 4,950,227, Imbert U.S. Pat. No. 4,875,480, Wallsten et al.U.S. Pat. No. 4,848,343, Wallsten et al. U.S. Pat. No. 4,732,152, Garzaet al. U.S. Pat. No. 4,665,918, Gould et al. U.S. Pat. No. 4,572,186,Strecker U.S. Pat. No. 6,485,524 B2, Klumb et al. U.S. Pat. No.6,488,700 B2, Klumb et al. U.S. Pat. No. 6,248,122 B1, Klumb et al. U.S.Pat. No. 6,238,430 B1, Harada et al. U.S. Pat. No. 5,037,427, McNamaraet al. U.S. Pat. No. 5,147,370, Kolobow et al. U.S. Pat. No. 6,027,516,Thorud et al. U.S. Pat. No. 6,019,779, Holman U.S. Pat. No. 5,980,533,St. Germain U.S. Pat. No. 5,836,966, Klein U.S. Pat. No. 5,797,952,Gunderson U.S. Pat. No. 5,776,142, Summers et al. U.S. Pat. No.5,772,668, Lukic et al. U.S. Pat. No. 5,709,703, Lenker et al. U.S. Pat.No. 5,683,451, Bergentz et al. U.S. Pat. No. 3,993,078, Myler et al.U.S. Pat. No. 5,474,563, Limon U.S. Pat. No. 5,476,505, St. Germain etal. U.S. Pat. No. 5,534,007, Roberts et al. U.S. Pat. No. 5,603,698,Boatman et al. U.S. Pat. No. 5,632,771, Myler et al. U.S. Pat. No.5,643,309, Strecker U.S. Pat. No. 6,485,524 B2, Augustine et al. U.S.Pat. No. 6,427,686 B2, Linder U.S. Pat. No. 5,664,567, Downing U.S. Pat.No. 4,821,715, Alfery U.S. Pat. No. 6,386,199 B1, Lane et al. U.S. Pat.No. 5,494,029, Grosbois et al. U.S. Pat. No. 6,474,339 B1, Bullard U.S.Pat. No. 5,791,341, Gianturco U.S. Pat. No. 4,580,568, Hart U.S. Pat.No. 5,950,624, Zammit U.S. Pat. No. 6,328,753 B1, Woodson U.S. Pat. No.6,161,541, Mark et al. U.S. Pat. No. 6,419,641 B1, Thompson et al. U.S.Pat. No. D458,679 S, Beyar et al. U.S. Pat. No. 6,371,979 B1, Beyar etal. U.S. Pat. No. 6,371,953 B1, Thompson U.S. Pat. No. 6,358,274 B1,Klima et al. U.S. Pat. No. 6,273,876 B1, Thompson U.S. Pat. No.6,254,631 B1, Thompson U.S. Pat. No. 6,132,461, Thompson U.S. Pat. No.6,132,460, Vidlund U.S. Pat. No. 6,110,164, Beyar et al. U.S. Pat. No.6,090,115, Vidlund et al. U.S. Pat. No. 6,033,394, Donadio, III U.S.Pat. No. 6,027,863, Johnson et al. U.S. Pat. No. 6,022,343, Thorud etal. U.S. Pat. No. 6,019,779, Dustrude et al. U.S. Pat. No. 5,911,752,Clubb et al. U.S. Pat. No. 5,815,904, Eliachar et al. U.S. Pat. No.5,048,518, Conrad et al. U.S. Pat. No. 6,450,169, Bibi U.S. Pat. No.6,371,112, Thornton U.S. Pat. No. 6,325,064, Thornton U.S. Pat. No.6,305,376, Thornton U.S. Pat. No. 6,374,824, Dutkiewicz U.S. Pat. No.6,257,236, Rittmann U.S. Pat. No. 6,270,512, Thorner U.S. Pat. No.6,238,411, Hurbis U.S. Pat. No. 6,106,541, Lundy, Jr. et al. U.S. Pat.No. 6,098,616, Muchin U.S. Pat. No. 6,058,931, Filis U.S. Pat. No.6,004,342, Christopher U.S. Pat. No. 5,954,050, Boussignac U.S. Pat. No.6,363,935, Muchin U.S. Pat. No. 5,718,224, Conrad et al. U.S. Pat. No.6,250,307, Conrad et al. U.S. Pat. No. 6,401,717, Conrad et al. U.S.Pat. No. 6,390,096, Berthon-Jones U.S. Pat. No. 6,123,082, Halstrom U.S.Pat. No. 6,161,542, Halstrom U.S. Pat. No. 5,868,138, Tielemans U.S.Pat. No. 6,408,852, Shapiro U.S. Pat. No. 5,117,816, Bergersen U.S. Pat.No. 6,129,084, Edwards et al. U.S. Pat. No. 6,126,657, Edwards U.S. Pat.No. 5,800,379, Edwards U.S. Pat. No. 5,738,114, Rotramel U.S. Pat. No.6,171,314, Anderson U.S. Pat. No. 5,893,365, Thomas U.S. Pat. No.5,988,170, Gaumond et al. U.S. Pat. No. 6,379,311, Belfer U.S. Pat. No.6,092,523, Richmond et al. U.S. Pat. No. 6,345,202, Meyer et al. U.S.Pat. No. 6,329,352, Estes et al. U.S. Pat. No. 5,970,975, Bourgeois etal. U.S. Pat. No. 6,126,611, Samelson U.S. Pat. No. 4,304,227, Dror U.S.Pat. No. 4,198,967, Gardy U.S. Pat. No. 4,676,240, Meade U.S. Pat. No.5,682,903, Alvarez et al. U.S. Pat. No. 5,649,540, Parks U.S. Pat. No.5,642,737, Hilsen U.S. Pat. No. 5,611,355, Zammit U.S. Pat. No.6,183,493, Eliachar U.S. Pat. No. 4,794,924.

It has been discovered that a number of the devices disclosed in theabove referenced patents, that are conventionally utilized or suggestedfor utilization in body regions other than the oropharyngeal regionand/or to treat conditions other than sleep apnea and/or snoring, can beutilized or modified to be utilized in the oropharyngeal region of ahuman or an animal in order to treat sleep apnea and/or snoring, inaccordance with the present invention. Any such modification ormodifications to such conventional devices are considered to be includedwithin the scope of the apparatus of the present invention. In addition,the use of any of such previous devices, and any modified such previousdevices, in the oropharyngeal region of a human or an animal in order totreat sleep apnea and/or snoring is considered to be within the scope ofthe methods of the present invention. It can be noted that currentlythere are no vascular or other stents marketed for use in natural bodyconduits which are designed to expand to diameters in excess of 32 mm.

For example, the at least one additional benefit or advantage of theapparatus of the present invention, relative to a device conventionallyutilized or suggested for utilization in body regions other then theoropharyngeal region and/or to treat conditions other than sleep apneaand/or snoring, may comprise, without limitation, at least one or moreof the following: the apparatus is structured to be located in theoropharyngeal region and to have an enhanced ability to be tolerated bythe human or animal, for example, while the human or animal is awake oris naturally sleeping; the apparatus is structured to provide enhancedresistance to static collapsing forces of the oropharyngeal regionand/or hypopharynx; the apparatus is structured to have an enhancedability to allow for dynamic collapse; the apparatus is structured tohave enhanced non-mobility, for example, upon coughing, throat clearingand/or sneezing; the apparatus is structured to have enhanced conformityto the healthy, normal shape of the pharynx; the apparatus is structuredto have an enhanced ability to be removable; the apparatus is structuredto have an enhanced ability to be deployable under direct vision vianasopharyngoscopy/laryngoscopy; and the like benefits.

In addition, the present apparatus preferably are structured to notsubstantially interfere with swallowing, respiration, vocalization,mucociliary function, epiglottis functioning and the like. For example,in some embodiments of the invention, the apparatus is structured to besubstantially aligned along and longitudinally with the oropharyngealwalls. The present apparatus are structured to maintain the openness ofthe pharyngeal region during natural sleep.

Turning now to FIG. 1, a cross-sectional anatomical view of a humanpatient 1 is shown. The patient 1 has apparatus 10 in accordance withthe present invention located within the patient's oropharyngeal region1 a in order to treat, for example, control, reduce or even eliminate,the occurrence of sleep apnea and/or snoring

Snoring and sleep apnea are often caused by a combination of narrownessand low muscle tone of the upper airways. The tongue 2 a falls back andmay obstruct the airway, possibly leading to an arousal reaction anddisturbing the normal sleeping pattern. Other portions of theoropharyngeal region may also collapse. For example, the lateral walls 2b of the oropharyngeal region often become excessively lax and block afree flow of air during respiration. When the patient 1 is supine, forexample, when the patient 1 is asleep and lying on his/her back, therelaxed tongue 2 a moves inferior (down) and posterior (back), and/orthe lateral walls 2 b of the oropharyngeal region collapse inwardlyresulting in a narrower pharynx relative to when the patient 1 isupright. One cause for the narrowing of the pharynx in the supineposition could be that the oropharyngeal region 1 a and hypopharyngealregion 1 b, which have low consistencies, collapse because of lack ofdirect hard tissue support.

The apparatus 10 may be secured to the pharyngeal region by variousmeans. For example, the apparatus 10 may be sutured to the pharyngealregion, for example with dissolvable sutures that will allow theapparatus 10 to be held in place while the apparatus 10 becomes fixed tothe region by means of tissue ingrowth. Alternatively, the apparatus 10may be secured to the region by means of a suitable biocompatibleadhesive as are presently known in the art. Alternatively still, theapparatus 10 may be secured to the region by being surgically implantedinto the region, for example, directly beneath the region's mucosallayer, (hereinafter, “submucosally”), for example, by being pulled, witha surgical needle for example, into and beneath the mucosal layer suchthat the apparatus at least partially circumscribes the region.

The apparatus 10 of the present invention is preferably designed toprovide direct support to at least some of these tissues when thepatient 1 is supine and asleep. For example, the apparatus 10 of thepresent invention is structured so that when placed in the givenposition in oropharyngeal region 1 a, the apparatus 10 will push thetongue forward, and/or push the lateral walls 2 b away from one anotherthereby holding the airway patent or open during the time the human oranimal is naturally sleeping.

As shown, the apparatus 10 may be sized and structured to be positionedadjacent the epiglottis 2 c of patient 1, but preferably not in contacttherewith. For example, in one embodiment of the invention, theapparatus 10 is designed to overlay a posterior wall 2 d of theoropharyngeal region 1 a and provide an opening force outwardly againstopposing lateral walls 2 b of the oropharyngeal region 1 a. In otherembodiments of the invention, the apparatus 10 is designed to restwithin a valecullar space 2 e and provide a pushing force against thebase 2 f of the tongue 2 a which makes up a portion of the anterior wall2 g of the oropharyngeal region 1 a. The valecullar space 2 e, as theterm is used herein, is defined as being the space between the anteriorwall 2 g of the throat and the upper tip 2 h of the epiglottis 2 c downto the conjunction of the epiglottis 2 c with the anterior wall 2 g ofthe pharynx.

In any event, the apparatus 10 is designed in such a manner as tosubstantially prevent same from interfering with the normal functioningof the tissue around the apparatus 10, particularly with the normalfunctioning of the epiglottis 2 c. The apparatus 10 may includestructures (as described elsewhere herein) for anchoring or securing theapparatus 10 within the oropharyngeal region 1 a in order to prevent theapparatus 10 from migrating away from or out of the given position.

Preferably, in all embodiments of the invention, the apparatus 10 isstructured to closely and flexibly conform to the size and contours ofat least a portion of the oropharyngeal region 1 a.

In one useful embodiment, the apparatus 10 can be said to be effectiveto provide a support substantially equivalent to the support of tissueand/or muscles of an oropharyngeal region in a healthy, toned state.

As a specific example, the apparatus 10 may be sized and shaped to fit ahuman patient having a measured anterior-posterior linear distancebetween the pharyngeal walls, when the patient is awake and not supine,and the tongue and/or other tissues are not fully lax.

The apparatus 10 is preferably structured to maintain a radial force orpressure, for example, a substantially constant radial force orpressure, against the oropharyngeal region, specifically against thelateral walls of the oropharyngeal region, the posterior portion of theoropharyngeal region, and/or the base of the tongue. The pressure of theapparatus maintained against this region is advantageously sufficient tomaintain patency of the oropharyngeal region during natural sleep in asupine position (for example, greater than about 10 cm of water), andpreferably exerts pressure less than that exerted by the surfaces of theoropharyngeal region during swallowing (for example, about 400 cm ofwater). The apparatus preferably has a hoop strength in a range of about5 cm water up to about 400 cm water. It is further noted that the designof apparatus 10 allows for variable hoop strength as measured alongdifferent points about the circumference of the appliance of theapparatus.

The present apparatus 10 is designed and structured to allowsubstantially normal functioning of the oropharyngeal and pharyngealregions, while maintaining the structural integrity of the apparatusover a long period of time. An important consideration in the design ofthe present apparatus 10 includes the requirement that the apparatus 10substantially maintain its structural integrity and strength despite thehighly dynamic, peristaltic motion of the oropharyngeal andhypopharyngeal regions.

For example, it is known that a human being typically swallows anaverage of two times a minute, throughout the day. This equals around2000 swallows per day. The force of the swallow varies from 1.5 lbs. to6 lbs. of pressure, and the force lasts for about 0.1 to about 0.2seconds.

Swallowing also includes the involuntary apposition of the soft palateto the posterior pharyngeal wall, which is believed to last almost asecond and producing a pressure of about 160 millimeters of mercury andinitiates pharyngeal peristalsis, i.e. the wavelike muscularcontractions that move food along the alimentary canal in the pharyngealregion. This moving front of contraction passes through the pharyngealconstrictors in sequence, traversing the pharynx and hypopharynx atabout 15 centimeters per second to reach the upper esophageal sphincterin about one second. The hypopharyngeal contraction lasts about 0.3 toabout 0.5 seconds and generates an intraluminal pressure of 200millimeters of mercury. The present invention is designed to flex andcontract along with this wave-like motion of the various muscles in theoropharyngeal and hypopharyngeal region.

The appropriate amount of force necessary to provide adequate support tomaintain patency and consistent air flow through the oropharyngealregion during sleep, while allowing for the dynamic motion of thepharyngeal region and normal function of the oropharyngeal region and/orhypopharyngeal region, may vary between patients. Therefore, preferablythe apparatus 10 is available in a range of radial forces and sizes inorder to suit different individuals.

Preferably, each of the embodiments of the apparatus in accordance withthe present invention are made of resilient and elastic biocompatiblematerials, for example, one or more metals, and all edges and surfacesare smooth and free of sharp portions, burrs and contaminants. Suchsmooth, or at least substantially smooth, edges and surfaces areeffective to reduce or inhibit fibrosis or other scar tissue formationin the pharyngeal region, which fibrosis or scar tissue formation caninterfere with the dynamic motion or normal functioning of thepharyngeal region. In one embodiment of the invention, the presentapparatus preferably is structured, for example is made of metal and/orhas substantially smooth edges and surfaces, to substantially reduce,more preferably to substantially eliminate, fibrosis of other scartissue formation. This is in contrast to the use of materials selectedto promote of induce fibrosis of other scar tissue formation.

FIGS. 2-6 show various embodiments of the invention that are generallycylindrical or tubular in structure. Except as expressly describedherein, each of the apparatus 10 a, 10 b, 10 c, 10 d and 10 e, shown inFIGS. 2-6 respectively, is similar to apparatus 10 and is structured,unless otherwise noted herein, to be utilized for the treatment of sleepapnea and/or snoring as hereinabove noted.

Turning now specifically to FIG. 2, apparatus 10 a is structured to fitsubstantially entirely within the oropharyngeal region and at leastpartially within the valecullar space and/or preferably extending nohigher than the upper surface of the base of the tongue in the anteriorportion of the apparatus. The posterior portion of the apparatus may bedesigned to provide additional support above the oropharyngeal region.

The appliance 12 defines a central open or hollow space 12 a and can bemade of any suitable biocompatible material, for example, stainlesssteel, other metals, or plastics (polymeric materials), and the like,and combinations thereof.

FIG. 3 shows an apparatus 10 b in accordance with the present inventioncomprising a substantially cylindrical appliance 14 similar to appliance12, with the most significant difference being that appliance 14 iscomprised of a mesh, for example a woven metal wire mesh. The meshappliance 14 defines a central open or hollow space 14 a and preferablycomprises wires 14 b made of a super-elastic material, for example, anickel titanium alloy (to be described in more detail elsewhere herein),such as the alloy known as Nitinol.

FIG. 4 shows an additional apparatus 10 c of the present invention,similar to apparatus 10 a, comprising a solid cylindrical appliance 16including a feature of a cut-out region 17 defined in the appliance 16,the cut-out region being appropriately sized, shaped, and positioned toaccommodate natural movements and functions of the epiglottis of thepatient. Thus, in this embodiment of the invention, apparatus 10 c isfitted to a patient with cut-out portion 17 facing an anterior wall ofthe oropharyngeal region. The epiglottis is therefore free to moveinwardly and outwardly of the appliance by means of the cut-out region.

Phantom lines in FIG. 4 illustrate another apparatus 10 c′ of theinvention comprising an appliance 16′ including longitudinal members 16a depending from a brace portion 16 b. The brace portion 16 b isstructured to be secured partially circumferentially to the pharyngealwalls, with depending members 16 a preferably being submucosallyimplanted within the pharyngeal walls. It is to be appreciated thatalthough only four members 16 a are shown, the appliance 10 c′ mayinclude any other number of members, having the same or differinglengths, depending upon the needs of an individual patient.

FIG. 5 shows yet another apparatus 10 d of the present invention,comprising an appliance 18 having a relatively wider diameter distal orlower portion 19 which functions to anchor or hold the appliance 18within the valecullar space. When in use, apparatus 10 d is anchored atportion 19 within the vallecular space allowing the epiglottis tofunction normally within the relatively wider hollow area defined by thelower portion 19.

FIG. 6 shows a further embodiment of the invention, specifically anapparatus 10 e generally comprising an appliance 20 having a helical orspiral spring including coils 22 comprising, for example, asuper-elastic material, as described elsewhere herein.

FIGS. 7-11 show various other embodiments of the invention that aregenerally non-circumferential in structure. Except as expresslydescribed herein, each of the apparatus 10 f, 10 g, 10 h, 10 i and 10 j,shown in FIGS. 7-11 respectively, is similar to apparatus 10 and isstructured, unless otherwise noted herein, to be utilized for thetreatment of sleep apnea and/or snoring as herein noted.

Turning now specifically to FIG. 7, the present invention preferablyprovides apparatus 10 f, comprising an appliance 26 that isnon-circumferential in structure. In other words, apparatus 10 f, unlikeapparatus 10 a-10 e, includes spaced apart end portions 27 defining agap 32, and a closed portion 34. The end portions 27 are preferablyrounded as shown.

More specifically, the appliance 26 may be described as comprising asubstantially C-shaped member 35 defining a pair of resilient, flexiblewire struts 36 a and 36 b connected at the end portions 27. The struts36 a and 36 b may have any suitable transverse cross-section, forexample, a circular, oval, rounded, flattened or the like transversecross-section. In this particular embodiment of the invention, themember 35 comprises a wire or ribbon that forms a continuous loop asshown, defining an open interior space 38.

Still referring to FIG. 7, the appliance 26 is structured to bepositioned within the oropharyngeal region with the end portions 27bearing against and providing an opening force against the lateral wallsof the oropharyngeal region. It is contemplated that the apparatus 10 fmay be alternatively positioned such that the appliance 34 restssubstantially within or entirely within the valecullar space and pressesagainst the base of the tongue along closed portion 34.

Upon contraction of the oropharyngeal region, for example, duringswallowing, the end portions 27 will be temporarily forced toward oneanother by the muscles in the oropharyngeal region, and may or may notoverlap or contact one another. The flexibility and relative spacing ofthe struts 36 a and 36 b allow the appliance 34 to contract and expandin vertical and horizontal directions as necessary, for example inconjunction with peristalsis of the pharyngeal walls upon swallowing.

Preferably, each of the embodiments of the present invention iscomprised of highly elastic, resilient, biocompatible materials. Inparticular, each of the non-circumferential apparatus in accordance withthe present invention preferably comprises a metallic material, and/or asuper-elastic material, more preferably, a nickel titanium (NiTi) alloy,such as the alloy known as Nitinol.

Intrinsically, the present appliances made of such metals such asNitinol provide reinforcement and/or support to the pharynx withoutaltering, or at least without substantially altering, the pharyngealtissues and without or interfering with the physiological structure ofthe pharyngeal tissue itself. Advantageously, the use of such metallicmaterials provides enhanced control of the degree of stiffening and/orreinforcement of the pharyngeal region because the intrinsic propertiesof the appliance itself, for example the dimensions and resiliencythereof, are relied upon to treat the patient's condition. This is incontrast to treating a patient with a device intended to induce orpromote one or more tissue reactions, for example, fibrosis, otherscarring of tissues and the like reactions, near the device to effectstiffening or other changes in the pharyngeal region.

For general background purposes, a description of the benefits ofNitinol for use in the present invention follows. Additional details ofthis alloy can be obtained from readily available sources and/or will beknown to those of skill in the art.

Nickel titanium (also known as Nitinol) is in the class of materialsknown as shape memory alloys. A thermoelastic martensitic phasetransformation in the material is responsible for its extraordinaryproperties. These properties include the shape memory effect,super-elasticity, and high damping capability.

Nitinol has the ability to absorb large amounts of strain energy andrelease it as the applied strain is removed. Nitinol also has excellenttorqueability and kink resistance, which is an important feature of theapparatus of the present invention due to the dynamic nature of theoropharyngeal and hypopharyngeal regions. Advantageously, super-elasticNitinol alloys provide a substantially constant force over a largestrain range.

The present apparatus more preferably comprise a Nitinol material, morepreferably with a ratio of the two constituents, nickel and titanium, atabout 50 atomic percent each (about 55 percent by weight of nickel).

The properties of Nitinol can be modified by changes in alloycomposition, mechanical working, and heat treatment, as known to thoseof ordinary skill in the art. The specific alloy used in the apparatusof the present invention is selected mainly for its super-elastic effectrather than its shape memory effect.

Super-elastic Nitinol alloys preferably are used in the apparatus of thepresent invention to take advantage of a stress-induced martensitictransformation in order to achieve extreme amounts of flexibility andkink resistance. It is known that an alloy of nickel and titanium canbehave super-elastically if its Active A_(f) temperature is just belowthe use temperature. For example, alloys which are intended to besuper-elastic at room temperature are generally produced with theirActive A_(f) temperatures just below room temperature in the range ofabout 0 to about 20° C. A super-elastic material will not besuper-elastic at all temperatures, but will exhibit good super-elasticproperties in a temperature window extending from the Active A_(f)temperature up to a temperature which is about 50° C. above ActiveA_(f). Therefore, a material with an Active A_(f) of about 15° C. willexhibit good super-elasticity up to about 65° C., which means that thematerial will exhibit good super-elasticity at both room temperature andbody temperature (37° C.).

Nitinol is the more preferred material for the apparatus of the presentinvention also due to its excellent biocompatibility, very highcorrosion resistance, and excellent cytocompatibility. In addition, thenickel in nickel/titanium alloy is chemically joined to the titanium ina strong intermetallic bond, so the risk of reaction, even in patientswith nickel sensitivity, is extremely low. Additional details on nickeltitanium alloys are known to those of ordinary skill in the art and areprovided, for example, in Jervis, U.S. Pat. No. 6,306,141, which isincorporated herein in its entirety by this specific reference.

FIGS. 8-10 show alternative embodiments of the invention similar to theembodiment shown in FIG. 7 in that the appliance is non-circumferentialas defined elsewhere herein.

More specifically, referring to FIG. 8, an apparatus 10 g in accordancewith the invention is shown that generally comprises a cuff-shapedappliance 50. Like appliance 26, appliance 50 includes spaced apart endportions 27 g defining a gap 32 g, and closed portion 34 g. Asubstantial distinction between apparatus 10 g and apparatus 10 f isthat apparatus 10 g comprises relatively wide, opposing outer peripheralportions 56 a and 56 b, that define flattened bands, rather than struts36 a and 36 b. The outer peripheral portions 56 a and 56 b define anopen interior space 58. Relative to apparatus 10 f, this particulardesign generally allows greater surface contact with oropharyngealtissues as well as greater hoop strength or opening pressure.

FIG. 9 shows an apparatus 10 h of the invention comprising a cuff-shapedappliance 60 similar to appliance 50 for accommodating a patient withdifferent needs, for example, a patient having a longer, more narroworopharyngeal region. Appliance 60 includes spaced apart end portions 27h defining a gap 32 h and closed portion 34 h.

FIG. 10 shows another apparatus 10 i in accordance with the invention,the apparatus 10 i being similar to the embodiment shown in FIG. 8. Asignificant distinction between apparatus 10 i and apparatus 10 g isthat the apparatus 10 i comprises a substantially mesh structure forproviding increased flexibility and/or to facilitate tissue ingrowth torestrict or prevent migration of the apparatus 10 i. For example, theappliance 64 comprises an outer peripheral portion 66 made of a wovenmesh wire for example, defining an interior space 68.

FIG. 11 shows yet another apparatus 10 j in accordance with the presentinvention, comprising a non-circumferential cuff-shaped appliance 82having spaced apart end portions 27 j defining a gap 32 j. A significantdistinction between apparatus 10 j and apparatus 10 g is that appliance82 does not include interior space 58, but is instead substantiallysolid as shown. In addition, appliance 82 preferably includes one ormore through apertures 87 for facilitating tissue ingrowth.

FIGS. 12-21 show various embodiments of the invention that are generallyplanar when in a resting or non-deployed state, for example, when theapparatus is located outside of the oropharyngeal region of a patient ina rest position. Except as expressly described herein, each of theapparatus 10 k, 10 m, 10 n, 10 p and 10 q, 10 s, 10 t, 10 u, 10 v and 10w shown in FIGS. 12-21 respectively, is similar to apparatus 10 and isstructured, unless otherwise noted herein, to be utilized for thetreatment of sleep apnea and/or snoring as herein noted.

Turning now to FIG. 12, apparatus 10 k, in accordance with the presentinvention, generally comprises an appliance 110 having a flat, orsubstantially planar configuration (represented by phantom lines) thatis flexible to achieve an arched, or curved configuration (shown insolid line). Like the embodiments of the invention shown in FIGS. 7-11,the apparatus 10 k defines a non-circumferential configuration when inthe deployed state.

More particularly, the appliance 110 comprises a body portion 112 andend portions 114 spaced apart by the body portion 112. The appliance 110may be in any suitable form, such as, for example, a substantiallyrectangular (shown in FIG. 12), a substantially circular form, asubstantially oblong form, a substantially oval form or a substantiallyelliptical form or the like configuration. When located in theoropharyngeal region, the appliance 110 is structured to exert asufficient force, more preferably a sufficient substantially constantradial force, on the oropharyngeal region, particularly against thelateral walls of the oropharyngeal region, to maintain or cause theairway passing through the region to be patent, so that it issubstantially open or unobstructed.

The appliance 110 is structured to take on a deployed configuration whenlocated within the oropharyngeal region such that the end portions 114are spaced apart from each other by other than the body portion 112. Forexample, the end portions 114 may be spaced apart by the epiglottis or aportion of the anterior or posterior wall of the oropharyngeal region.The apparatus 110 is structured to be sufficiently resilient andflexible to allow for normal dynamic movement or motion of theoropharyngeal region with little or no loss in desirable properties,such as hoop strength and the like, over an extended period of wear.

Advantageously, the apparatus 10 k may be formed entirely from a unitaryflat sheet of material that is laser cut into the desired configuration.Using a flat elastic or super-elastic sheet of material or a sheetpre-curved to a diameter larger than that of the oropharyngeal region ofthe human or animal, the apparatus 10 k, once implanted into theoropharyngeal region, applies substantially continuous opening pressureto the oropharyngeal walls, for example, the lateral walls of theoropharyngeal region.

Appliance 110 may have a length of between about 50 mm and about 90 mmin the substantially flat configuration, and a height of between about15 mm and about 25 mm. The dimensions of appliance 110 are selectedbased on individual patient need. The appliance is designed such thatthe effective non-constrained diameter of the appliance, when deployed,is greater than about 32 mm.

Appliance 110 comprises a plurality of flexible wire or ribbon struts140, which preferably extend between the radiused end portions 114extending along a substantial portion of the length of the appliance110. For example, the appliance 110 may comprise between about 2 andabout 50 struts or more, and preferably between about 6 and about 20struts, such as about 10 struts.

In the embodiment shown in FIG. 12, each of the struts 140 has athickness of about 0.005 inch and a width of about 0.010 inch. Thisdesign has been found to provide the required flexibility and resiliencyin at least three dimensions or directions of motion, and preferably, inaddition, twisting motion, without exhibiting significant fatigue overan extended period of wear/time in service requiring dynamic movement,such as in the oropharyngeal region.

The number, thickness, and width of the struts 140 may be varied toproduce a desired opening pressure (e.g., hoop strength) on the base ofthe tongue or to reduce or increase the surface area of the struts 140which are in contact with the oropharyngeal walls. This design alsoallows improved vertical collapse/deformation of the oropharyngealregion, for example, allowing peristalsis type movement duringswallowing.

When provided in an oropharyngeal region of a patient for the treatmentof sleep apnea and/or snoring, the appliance 110 is curved with a convexsurface pressing against the tissues to be supported, particularly thelateral walls of the oropharyngeal region and/or the base of the tongue.

The appliance 110 is structured to be self-expanding with a controlledlength during such expansion. This can be achieved by suitable selectionof super-elastic materials, preferably Nitinol, and appropriateselection of strut length and other dimensions. The appliance 110 alsois preferably structured to have a relatively atraumatic nature of allsurfaces thereof and of the curved end portions. In addition, theappliance 110 is structured to exhibit the ability to be delivered in aminimal diameter access manner by rolling the appliance 110 onto itselfwithin a catheter, inserter tube and the like.

The appliance 110 may be tailored to be effective in a variety ofpatients and in a variety of different body regions that would benefitfrom the consistent support provided by such an appliance. For example,the size and structure of the appliance can be selected to accommodate aspecific need. The amount of force provided by the appliance can bemodified by appropriate selection of the number of struts, width and/orthickness of struts, and/or surface area covered by the struts and/orthe like factors. Generally, as the struts become thinner and take upless surface area, the appliance 110 will become more compliant and willmove and flex with less radial force exerted thereby and will flex to agreater extent without permanent deformation. It is noted that a portionof appliance 110 may be modified such that it will function to anchor orsecure the appliance in place. For example, an outer or peripheral strut140 a may be configured to achieve a “fluted” configuration. In someembodiments, although not shown, one or more of the struts may be shapedas wave forms or s-shapes. In yet other embodiments, although not shown,cushioned end members may be provided on the end portions 114 of theappliance 110 in order to enhance comfort and/or proper fit.

An optional feature of the invention is shown at 141 for facilitatinganchoring of the apparatus 10 k in the given position. Morespecifically, at least one of the struts 140 b may be configured to formbarbed portions 145 a and 145 b for enhancing secure attachment of theappliance 110 to the posterior wall of the oropharyngeal region. It isalso contemplated that other means for securing the apparatus 10 k inthe given position may be provided, for example, surfaces of theapparatus 10 k may be coated with a biologically compatible glue oradhesive.

FIG. 13 shows another apparatus 10 m including appliance 210 fortreating sleep apnea and/or snoring, in accordance with the presentinvention. Apparatus 10 m is similar to apparatus 10 k, with anadditional feature shown on apparatus 10 m being the addition of spacingportions 242, positioned and structured to maintain a spaced apartrelationship between adjacent struts 240 when apparatus 10 m is in theoropharyngeal region of a patient. Appliance 210 includes end portions214 and body portion 212.

FIGS. 14 and 15 show apparatus 10 n and 10 p respectively, for treatingsleep apnea and/or snoring, in accordance with the present invention.Apparatus 10 n and apparatus 10 p are similar to apparatus 10 k and 10m, with the most significant distinction being that apparatus 10 n and10 p are substantially oval or elliptical rather than rectangular inshape. Apparatus 10 n generally comprises appliance 310 includingrounded end portions 314 joined by body portion 312, and a plurality ofspaced apart struts 340. Apparatus 10 p generally comprises appliance410 including rounded end portions 414 joined by body portion 412, and aplurality of spaced apart struts 440 and spacing portions 442.

FIG. 16 shows yet another apparatus 10 q for treating sleep apnea and/orsnoring in accordance with the present invention. As shown, apparatus 10q comprises an appliance 510 having a substantially elliptical shape andincluding a plurality of bowed or arched struts 545 that converge at endportions 514.

Turning now specifically to FIGS. 17-21, additional alternativeembodiments of the present invention are shown. Like the embodiments ofthe invention shown in FIGS. 12-16, these embodiments are typicallyplanar in structure when at rest and not deployed in the oropharyngealregion of a patient. A significant distinction between the embodimentsshown in FIGS. 12-16 and the alternative embodiments shown in FIGS.17-21, is that the latter embodiments each preferably define a singlecontinuous loop.

More specifically, FIG. 17 shows an apparatus 10 s for treating sleepapnea and/or snoring in accordance with the present invention,comprising a substantially cross-shaped appliance 610, defined by asingle loop element 612. The appliance 610 preferably is cut, morepreferably photoetched, from a single sheet of material, preferably asheet comprising a Nitinol superelastic alloy material, and preferablyhaving a sheet thickness of about 0.01 inch to about 0.1 inch. Element612 preferably has a substantially uniform width of between about 1 mmto about 5 mm or greater. The appliance 610 preferably has a height Halong a vertical axis of about 15 mm to about 25 mm, and a length Lalong a horizontal axis of about 60 mm to about 90 mm allowing aneffective non-constrained diameter of greater than about 32 mm. Thecross-shaped appliance 610 preferably is symmetrical about its verticaland horizontal axes. Appliance 610 includes vertical portions 616 a and616 b each defining an angle α, and horizontal portions 618 a and 618 beach defining an angle β.

For purposes of example only, not to be considered limiting the scope ofthe present invention, vertical portions 616 a and 616 b define apeak-to-peak measurement (i.e. height H) of about 25 mm, and horizontalportions 618 a and 618 b define a peak-to-peak measurement (i.e. lengthL) of about 70 mm. Also for purposes of this specific example only, eachof vertical portions 616 a and 616 b defines an angle α of about 15° andeach of horizontal portions 618 a and 618 b defines an angle β of about6°.

Appliance 610 is structured to be placed in the oropharyngeal region ina position such that horizontal portions 618 a and 618 b rest againstand provide support to the lateral walls of the oropharyngeal region.The vertical axis of the apparatus 610, generally defined by verticalportions 616 a and 616 b, are disposed against or adjacent the posteriorwall of the oropharyngeal region.

FIG. 18 shows yet another apparatus 10 t for treating sleep apnea and/orsnoring in accordance with the present invention. Apparatus 10 t issimilar to apparatus 10 s in that it is defined by a single loop element712 cut from a single sheet of material, for example, a Nitinol alloy. Asubstantial distinction between apparatus 10 s and apparatus 10 t isthat, rather than comprising a cross-shaped appliance 610, apparatus 10t comprises a substantially X-shaped appliance 710 having a length L anda height H. Appliance 710 includes multiple leg portions 717 a, 717 b,717 c and 717 d extending from a generally central region 720, whereinpaired leg portions 717 a and 717 c and paired leg portions 717 b and717 d, both define an angle (P. For purposes of this specific exampleonly, not to be considered limiting the scope of the present invention,appliance 710 has a length L of about 70 mm and a height H of about 25mm, and angle φ is about 36°.

Appliance 710 is structured to be placed in the oropharyngeal region ina position such that leg portions 717 a, 717 b, 717 c and 717 d restagainst and provide support to the lateral walls of the oropharyngealregion, and the generally central portion 720 is disposed against oradjacent the posterior wall of the oropharyngeal region.

FIG. 19 shows yet another apparatus 10 u for treating sleep apnea and/orsnoring in accordance with the present invention. Apparatus 10 u issimilar to apparatus 10 s in that it is defined by a single loop element812 cut from a single sheet of material, for example, a Nitinol alloy.Apparatus 10 u comprises an appliance 810 having a relatively narrow,generally central body portion 814 (having height H₁) terminating atrelatively wide end portions 816 a and 816 b (having height H₂), and alength L. End portions 816 a and 816 b preferably define angle γ asshown.

For purposes of this specific example only, not to be consideredlimiting the scope of the present invention, appliance 810 has a lengthL of about 85 mm, a height H₁ of about 10 mm, a height H₂ of about 35mm, and an angle γ of about 75°. Element 812 has a width W₁ at generallycentral portion 814 and a width W₂ of about 5 mm at end portions 816 aand 816 b.

Appliance 810 is structured to be placed in the oropharyngeal region ina position such that end portions 816 a and 816 b rest against andprovide support to the lateral walls of the oropharyngeal region, andthe generally central body portion 814 is disposed against or adjacentthe posterior wall of the oropharyngeal region.

FIG. 20 shows yet another apparatus 10 v for treating sleep apnea and/orsnoring in accordance with the present invention. Apparatus 10 vcomprises an appliance 910 comprising loop element 912, and including agenerally central body portion 914, and multiple end portions 916 a, 916b, 916 c and 916 d. As shown adjacent end portions define an angle η.Appliance 910 further includes a vertical portion 950 that defines anangle δ.

Appliance 910 is structured to be placed in the oropharyngeal region ina position such that multiple end portions 916 a, 916 b, 916 c and 916 drest against and provide support to the lateral walls of theoropharyngeal region, and the generally central body portion 914 isdisposed against or adjacent the posterior wall of the oropharyngealregion.

FIG. 21 shows yet another apparatus 10 w for treating sleep apnea and/orsnoring in accordance with the present invention. Apparatus 10 wcomprises an appliance 1010 that is somewhat similar to appliance 910 inthat appliance 1010 includes a generally central body portion 1014 andmultiple end portions 1016 a, 1016 b, 1016 c and 1016 d. Appliance 1010has somewhat different proportions, including a relatively wide uppercentral portion 1019 that is configured to provide enhanced tissuesupport to portions of the posterior wall of the oropharyngeal region,relative to tissue support provided by appliance 910.

FIGS. 22-23 show other embodiments of the invention for treating sleepapnea and/or snoring. Like the embodiments of the invention shown inFIGS. 12-22, these embodiments are typically planar in structure when atrest and not deployed in the oropharyngeal region of a patient.

FIG. 22 shows an apparatus 10 x in accordance with the inventioncomprising a substantially symmetrical appliance 1110 including asubstantially linear body portion 1112 and a plurality of struts 1118extending from the body portion 1112, for providing support to theoropharyngeal tissues. The number and length of struts 1118 preferablyare selected based on a particular patient need. For purposes of exampleonly, appliance 1110 may have an upper portion 1120 having about twopairs of struts 1118 defining a tip to tip length L₁ of about 62 mm, anda lower portion 1122 having about five pairs of struts 1118 defining atip to tip length L₂ of about 82 mm.

FIG. 23 shows an apparatus 10 y in accordance with the invention that issimilar to apparatus 10 x. The most significant distinction is thatapparatus 10 y comprises an appliance 1210 that includes a body portion1212 and struts 1218 that are offset from one another along body portion1212.

Turning now to FIG. 24, a preferred embodiment of the invention isshown, generally at 10 z. Apparatus 10 z is similar to apparatus 10 athrough apparatus 10 x in that apparatus 10 z is structured to beeffective in maintaining patency of the airway of a patient 1, forexample, the oropharyngeal region 1 a of a patient. However, apparatus10 z is specifically structured to be at least partially, and in somecases substantially entirely submucosally, implantable into thepharyngeal region, for example the oropharyngeal region, of the patient.

Apparatus 10 z, more clearly shown in FIG. 25, preferably comprises asingle elongated element 1401 having end portions, for example, roundedend portions 1406 and a body portion 1408 extending or connectedtherebetween.

As shown, end portions 1406 are preferably structured to facilitateimplantation, for example, surgical implantation, of the element 1401.For example, end portions 1406 may include appropriately sized apertures1410 for receiving suturing thread. The element 1401 may have a roundedcross-section such as shown in FIG. 25 a, or a polygonal cross section,for example a rectangular cross section, such as shown in FIG. 25 b.

Referring still to FIG. 25, element 1401 preferably has a length L ofbetween about 50 mm and about 70 mm and a width W of between about 2 mmor less and about 6 mm. Dimensions of the appliance 1400 may be at leastin part based upon, for example, the size or diameter of the patient'spharyngeal region and the specific portion of the pharyngeal region tobe supported by the apparatus 10 z. A typical area of support asmentioned elsewhere herein, is the area encompassing, at least, aportion of one or more of the lateral walls of the oropharyngeal region.

Appliance 1400 may comprise a metallic material such as Nitinol, or anon-metallic material such as Dacron®, or any suitable, flexible,elastic, resilient biocompatible material as discussed elsewhere herein.

Advantageously, the element 1401 is designed to be surgicallyimplantable in the pharyngeal region, at least partially circumscribingthe region, and at least partially, preferably substantially entirely,beneath the mucosal layer thereof. The appliance 1400 may also be atleast partially sutured to the pharyngeal tissues, for example, at endportions 1401 a of the element 1401, and/or secured to the oropharyngealtissues by means of a biocompatible adhesive.

Turning now to FIG. 26, appliance 1400 is shown sized to be placed atleast partially circumscribing an interior hollow passage (representinga cross-section of the airway of the patient) defining the pharyngealregion. This view (as well as views shown in FIG. 27 and FIG. 28) is asimplified representation of a cross-section of the oropharyngeal region1 a, with posterior wall 2 d and anterior wall 2 g, (which includes thebase 2 f of the tongue 2 a) and opposing right and left lateral walls 2b. This placement of appliance 1400 is effective in providing support tothe lateral walls 2 b of the oropharyngeal region 1 a. The appliance1400 is shown substantially entirely submucosally implanted.

Turning now to FIG. 27, appliance 1400 is shown sized to be placedcircumscribing, at least one full circumference of, the interior hollowspace defined by the pharyngeal region. In this case, the appliance 1400is sized to traverse the base 2 f of the tongue 2 a, for example,beneath the mucosal tissue thereof. The appliance 1400 is shownpartially submucosally implanted.

FIG. 24 a shows another apparatus, generally at 10 za, in accordancewith the present invention. Apparatus 10 za is substantially similar toapparatus 10 z, except that apparatus 10 za comprises an appliance 1400a including a plurality of elongated, spaced apart elements, for exampleat least two, or three or even more spaced apart elements 1401 a, 1401b, and 1401 c, depending upon the specific needs of a particularpatient. Except as indicated elsewhere herein, it is to be appreciatedthat elements 1401 a, 1401 b and 1401 c are structured to be placed, forexample, at least partially submucosally, implanted in a manner asdescribed hereinabove with respect to element 1401.

Each element 1401 a, 1401 b, and 1401 c may be substantially, entirelyindependent, or unitary, in structure with respect to each other element1401 a, 1401 b, and 1401 c. Alternatively, the multiple elements 1401 a,1401 b, and 1401 c may be secured to each other by suitable means, forexample, suturing, wire, ribbon or the like, for substantiallymaintaining the spaced apart relationship between the elements 1401 a,1401 b, 1401 c when the elements 1401 a, 1401 b, 1401 c are positionedwithin and secured to the pharyngeal region.

In a related embodiment of the invention, a method is provided formaintaining patency of a pharyngeal region. Particularly, the method maycomprise the step of at least partially submucosally placing at leastone elongated element within the pharyngeal region, for example theoropharyngeal region in one or more strategic locations, wherein theplacement thereof will cause the region to be stiffened or strengthenedagainst collapse during natural sleep.

To illustrate another optional feature of the present invention, FIG. 28shows a simplified view of the oropharyngeal region 1 a of a patient,having apparatus 10 zb in accordance with an embodiment of theinvention, submucosally implanted therein. FIG. 28 may represent anapparatus 10 zb comprising one or more magnetic components 1500 a and1500 b, structured and designed to be effective to provide a magneticfield useful for providing gentle, substantially constant and continuousresistance against collapse of the pharyngeal walls, particularly thelateral walls 2 b of the oropharyngeal region 1 a, for example duringnatural sleep, while allowing substantially normal functioning of thepharyngeal region, for example during swallowing.

In the example shown, the two magnetic components 1500 a, 1500 b arestrategically placed within the oropharyngeal region 1 a such that likemagnetic poles (i.e. repellant magnetic poles) are positionedsubstantially facing one another to create a magnetically repellantforce therebetween (indicated in simplified form by arrows 1502). Therepellant force caused by the strategically placed magnetic components1500 a and 1500 b is effective for providing an opening force within theoropharyngeal region, thereby maintaining patency of the region duringnatural sleep while still allowing constriction of the region duringswallowing.

FIG. 28 is also provided to illustrate an embodiment of the invention inwhich the apparatus 10 zb comprises elongated, non-magnetic, metallic,non-fibrosis inducing elements 1500 a and 1500 b, shown in crosssectional view, and being elongated, that is extending horizontallywithin the pharyngeal wall with the patient in the supine position, thatis, substantially parallel to the longitudinal axis defined by thepharyngeal walls. In this embodiment, the elements 1500 a and 1500 b areimplanted submucosally parallel to a longitudinal axis defined by thepatient's pharynx. Although only two such elements 1500 a and 1500 b areshown, it is to be appreciated that only one such element, or more thantwo such elements, may be implanted into the patient depending onindividual patient needs. Also, the size, dimensions and shape of suchelement or elements may be varied, for example depending on the needs ofthe patient being treated.

FIG. 29 shows a simplified perspective view of another apparatus 1600 inaccordance with the present invention. Apparatus 1600 comprises anappliance 1610 including an element 1612 having a transverse portion orcomponent 1620 with spaced apart ends 1620 a and 1620 b, and twosubstantially longitudinal portions or members 1622 a and 1622 bdepending from, and spaced apart by, the transverse portion 1620.Apparatus 1600 is a single, unitary structure made of metal, e.g.Nitinol and the like, or other material so as to inhibit or evensubstantially eliminate fibrosis or a fibrotic response or reaction fromthe pharyngeal tissues when the apparatus is placed in the pharyngealregion.

Preferably, each of the two longitudinal portions 1622 a and 1622 bdepends from a corresponding spaced apart end 1620 a and 1620 b,respectively, of the transverse portion 1620, as shown in FIG. 29.

Advantageously, the transverse portion or component 1620 is sized andstructured to be situated along the posterior wall, and possibly atleast a portion of the lateral walls, of the oropharyngeal region, toprovide a radial force, or an opening force to the walls of thepharyngeal region. The transverse portion 1620 may be secured to thewalls of the oropharyngeal region by any suitable means, including oneof the many means described elsewhere herein with respect to otherembodiments of the present invention.

In one aspect of the invention, the appliance 1610 is surgicallyimplanted into the oropharyngeal region such that the transverse portion1620 is at least partially submucosally implanted along the posteriorwall of the oropharynx, and the longitudinal portions 1622 a and 1622 bare implanted in substantial alignment with, for example, substantiallyparallel to, the longitudinal axis of the pharynx or pharyngeal region,for example, within opposing lateral walls of the oropharynx.Preferably, the longitudinal portions or members 1622 a and 1622 b aresubstantially entirely submucosally implanted within the pharyngealregion.

FIG. 29A shows a simplified perspective view of another apparatus 1700of the invention substantially similar to the apparatus 1600 shown inFIG. 29. Unless otherwise expressly specified, apparatus 1700 issubstantially identical to apparatus 1600, with like elements indicatedby like reference numerals increased by 100. Apparatus 1700 is placed inthe pharyngeal region in substantially the same way that apparatus 1600is so placed.

Apparatus 1700 comprises appliance 1710 having a sloping, for examplebut not limited to, a downwardly sloping, transverse portion 1720 andtwo longitudinal portions 1722 a and 1722 b depending therefrom. Inother words, whereas appliance 1610 defines a substantially 90 degreeangle between the transverse portion 1620 and the longitudinal portions1622 a and 1622 b, the appliance 1710 defines an acute, or alternativelyan obtuse (not shown), angle between the transverse portion 1720 and thelongitudinal portions 1722 a and 1722 b.

In other related aspects of the invention, the appliance may have atransverse portion that defines a first angle with one of thelongitudinal portions 1722 a and 1722 b and a second, different anglewith the other one of the longitudinal portions 1722 a and 1722 b.

It is to be appreciated that the desired configuration of the apparatus1600 or 1700, in many cases, will depend at least in part on the needsof the individual patient being treated.

The transverse portion 1720 of apparatus 1700 provides an additionalamount of longitudinal support as well as a radial opening force to theoropharyngeal region. In alternate embodiments of apparatus 1700, thesloping transverse portion 1720 can be used with only one of thelongitudinal portions 1722 a and 1722 b or without either or any ofthese longitudinal portions. In addition, apparatus including bothtransverse portions 1620 and 1720, with or without the longitudinalportions 1622 a, 1622 b, 1722 a and/or 1722 b, can be employed.

FIG. 30 shows another embodiment of the invention substantially similarto the embodiment shown in FIG. 29, wherein the apparatus 1800 comprisesan appliance 1810 in a substantially planar, substantially, for example,radiused, squared U-shaped configuration. Like apparatus 1600, apparatus1800 includes a transverse portion 1820 and longitudinal portions 1822 aand 1822 b depending therefrom. Unless otherwise expressly specified,apparatus 1800 is structured, is placed in the pharyngeal region, andfunctions substantially identically to apparatus 1600.

In apparatus 1800, transverse portion 1820 is substantially planar, thatis not substantially bow shaped, when the appliance 1810 is at restoutside of the human or animal body.

Like appliance 1610, appliance 1810 is structured to be positionedwithin the pharyngeal region, for example, the pharyngeal walls, withtransverse portion 1820 extending against the posterior oropharyngealwall and a portion of the lateral walls of the pharyngeal region, andlongitudinal portions 1822 a and 1822 b extending downwardly, preferablysubmucosally, within the pharyngeal walls, for example, within opposingsidewalls or lateral walls of the oropharyngeal region.

Transverse portion 1820 may have a length of about 0.787 inch (about 20mm) and longitudinal portions 1822 a and 1822 b may each have a lengthin a range of about 1.18 inches (about 30 mm) to about 1.97 inches(about 50 mm). Appliance 1810 may have a thickness, for example, asubstantially uniform thickness, of about 0.039 inch (about 1.0 mm). Thedimensions set forth herein are illustrations and are not intended tolimit the present invention. Any of such dimensions may vary widely, forexample, by ±about 10%, or ±about 20%, or ±about 40%, or about ±60%, ormore, so that the apparatus in accordance with the present invention maymeet the treatment needs of a wide variety of individual patients.

FIG. 30A shows a magnified view of a radius of curvature of an outeredge of the radiused angle between longitudinal portion 1822 a andtransverse portion 1820. The radius of curvature may be about 0.040 inch(about 1.0 mm).

FIG. 30B shows a magnified view of a radius of curvature of a distal endof one of the longitudinal portions 1822 a and 1822 b. This radius ofcurvature may be about 0.020 inch (about 0.50 mm).

FIG. 30C shows a side view of the apparatus of FIG. 30 in order toillustrate the relatively thin nature of the apparatus 1800, theapparatus 1800 having a thickness of about 0.008 inch (about 0.20 mm).

When outside the body of the patient, for example, prior to submucosalimplantation, the apparatus at rest may have a substantially planarprofile as shown in FIG. 30. This configuration is provided in order tosimplify and facilitate implantation of the apparatus 1800. Onceimplanted, the apparatus 1800 conforms to the wall, for example theposterior wall and a portion of the lateral walls, of the pharyngealregion while providing both radial and longitudinal support thereto.

Apparatus 1800 is substantially planar as shown in FIG. 30 after beingcut from a planar sheet of material, for example, a metallic material,for example, Nitinol. In an alternative aspect of the invention,apparatus 1800 is heat treated prior to implantation, to take on acurved configuration, for example, similar to the curved configurationof apparatus 1700 shown in FIG. 29. The degree of curve may be selectedbased upon the needs of a particular patient. The heat treated curvedapparatus 1800 may then be implanted into the pharyngeal regiondescribed elsewhere herein.

FIG. 31 shows a plan view of another apparatus 1900 for treating sleepapnea and/or snoring, in accordance with the present invention. Theapparatus 1900 comprises an appliance 1910 including at least onesubstantially bow shaped element 1920. Apparatus 1900 is made ofmaterials, e.g., metals, and includes only substantially smoothsurfaces, preferably with no abrupt or sharp edges, to reduce orsubstantially eliminate fibrosis, as discussed previously with regard toapparatus 1600, 1700 and 1800.

The bow shaped element 1920 is structured to be substantially entirelysubmucosally implanted within the pharyngeal region, for example along aposterior wall and/or a lateral wall of the oropharyngeal region toprovide an opening force to the region, such as described elsewhereherein. In one aspect of the invention, element 1920 has a thicknesssmaller than a length thereof, and is further sized and structured suchthat, when placed in the pharyngeal region, the element 1920 extendsalong the pharyngeal wall longitudinally a distance greater than thethickness of the element. For example, the element 1920 may be sized andstructured to be placed somewhat angularly with respect to alongitudinal axis of the pharynx or pharyngeal region as distinguishedfrom being sized and structured to be placed directly traverse orperpendicular to the longitudinal axis of the pharynx.

The at least one element 1920 may, in some embodiments of the invention,comprise a plurality of such elements 1920, meaning two or more suchelements 1920, with each element having the same or different dimensionsand structured and sized to be placed in a spaced apart, for example,laterally and/or longitudinally spaced apart, relationship within thepharyngeal region. Alternatively, the two or more bow shaped elements1920 may be structured and sized to be placed in the pharyngeal regionin a crosswise arrangement, for example, in an arrangement such that theelements 1920 overlap or cross one another, or in any other suitablearrangement effective to treat sleep apnea and/or snoring.

Depending upon where support is needed, and/or depending upon an amountor degree of support or reinforcement needed in a particular patient,and/or depending on one or more other factors, the element or elements1920 may be disposed generally horizontal or perpendicular to thelongitudinal axis of the pharynx or pharyngeal region or, alternatively,at any other suitable angle thereto.

Referring to both FIGS. 31 and 31A, element 1920 may substantiallydefine an arc having a radius of curvature of about 2.481 inches (about63 mm). Each end of the element 1920 may have a radius of curvatureabout 0.020 inch (about 0.50 mm). Element 1920 may have a length L,measured in a straight line between ends of the element 1920, of about1.964 inches (about 50 mm) and an arched width W of about 0.196 inches(about 5.0 mm), as shown. The element 1920 may have a width, forexample, a substantially uniform width along the arc of the element1920, of about 0.039 inch (about 1.0 mm). The element 1920 may have athickness of about 0.008 inch (about 0.20 mm).

FIG. 32 shows a plan view of another apparatus 2000 comprising anapparatus 2010 including an element 2020 that, like element 1920, issubstantially arcuate or bow shaped. This embodiment of the invention issubstantially identical to the embodiment, apparatus 1900, shown in FIG.31 and FIG. 31A, with the exception of some of the dimensions thereof.

Referring to both FIGS. 32 and 32A, element 2020 may substantiallydefine an arc having a radius of curvature of about 1.392 inches (about35 mm). Each end of the element 2020 may have a radius of curvatureabout R 0.020. Element 2020 may have a length L, measured in a straightline between ends of the element 2020, of about 1.964 inches (about 50mm), an arched width W of about 0.394 inch (about 10 mm). The element2020 may have a width, for example, a substantially uniform width alongthe arc of the element 2020, of about 0.039 inch (about 1.0 mm). Theelement 2020 may have a thickness of about 0.008 inch (about 0.20 mm).

It will be appreciated by those of skill in the art that not allpossible variations of the apparatus for treating sleep apnea and/orsnoring are shown, and that there are many other variations of theapparatus that are structured and shaped to provide specific support todifferent areas of the pharyngeal region, for example, the oropharyngealregion in order to treat sleep apnea and/or snoring, and based on thespecific needs of a particular patient. Each of these variations isconsidered to be within the scope of the present invention.

In yet another broad aspect of the present invention, methods areprovided for maintaining patency of a pharyngeal region, for example,the oropharyngeal region, in order to substantially reduce theoccurrence of sleep apnea and/or snoring. These methods in accordancewith the invention comprise, for example, steps of strengthening,reinforcing and/or stiffening tissues of the region which are subject tocollapse during natural sleep. For example, this may be accomplished byany one or more of the following steps: injecting an agent into thetissues which will cause partial necrosis of portions of the tissues inthe region, thereby stiffening the region; injecting, into the tissues,a liquid or gel agent that solidifies within the region to provide areinforcement against collapse of the region; mechanically or chemicallyirritating the tissues to cause a tissue reaction that firms the tissuesof the region; and applying a wave energy to the tissues to cause atissue reaction that firms the tissues of the region, for example, butnot limited to ultrasonic energy, radiofrequency energy, thermal energy(either adding thermal energy to the tissues or chilling the tissue byremoving thermal energy). Combinations of two or more of these steps maybe advantageously employed.

A preferred method for maintaining patency of a pharyngeal region, inaccordance with the present invention, generally comprises providing amember, for example elongated element 1401, element 1920, element 2020,in a substantially flat or precurved configuration. The member has abody portion and end portions spaced apart by the body portion. Themember is implanted, at least partially submucosally, within thepharyngeal region, preferably the oropharyngeal region, such that themember is effective to provide a substantially constant force against atleast a portion of each of the lateral walls of the region.

Preferably, the step of implanting comprises implanting the member intothe pharyngeal region such that the member is substantially entirelysubmucosally implanted in the pharyngeal region.

For example, the member may be implanted into oropharyngeal tissues,preferably directly beneath the mucosal layer, by using a curvedsurgical needle to weave or otherwise introduce the member into andbeneath the submucosal tissue.

In another embodiment of the invention, the method comprises the stepsof providing an apparatus in the oropharyngeal region of the human oranimal, for purposes other than surgery. The apparatus is effective intreating sleep apnea and/or snoring and/or in maintaining patency of theoropharyngeal region during natural sleep of the human or animal,without causing substantial interference with one or more naturalfunctions of the epiglottis.

Each of the apparatus for treating sleep apnea and/or snoring describedand shown elsewhere herein are suitable for use in the methods of thepresent invention. It is to be appreciated, however, that the apparatusused for performing the methods of the invention may take other forms aswell. For example, it is contemplated herein that a conventional stentmay be used in maintaining the airway in the pharyngeal region, forexample, the oropharyngeal region in an open state, and such use isconsidered to be within the scope of the methods of the presentinvention. The apparatus used in the methods of present invention may bedevices, for example but not limited to, a conventional stent, sized andstructured for placement in another region of the human or animal otherthan the pharyngeal region, for example, the oropharyngeal region.

In another embodiment of the invention, a method for maintaining patencyof a pharyngeal region of a patient comprises the steps of providing anapparatus in a first configuration, for example a rolled, coiled, orotherwise deformed configuration; inserting the apparatus into theoropharyngeal region, for example through the oral or nasal cavity ofthe patient while the apparatus is in a first configuration; and,thereafter, allowing the apparatus to reconfigure or expand to adeployed second configuration, for example a substantially cuff shaped,C-shaped, or other suitable deployed configuration, within theoropharyngeal region.

Any suitable deployment assembly useful for inserting the apparatusthrough the mouth or oral cavity, or nasal cavity of a patient and intothe oropharyngeal region may be utilized in accordance with the methodsof the present invention.

For example, a suitable deployment assembly includes an outer tube(about 10 mm diameter) and inner tube (about 8 mm diameter) disposedwithin the outer tube. A retaining clip may be used to fix the tubes inplace with respect to each other. The appliance, for example in rolledform, is provided within the outer tube at a distal portion thereof.Graspers, having a manually manipulable proximal portion may be providedthrough the tubes for assisting in positioning or removal of theappliance.

During insertion through the mouth or oral cavity of the patient, thedeployment assembly is advanced past the tongue of the patient until theinner diameter of the outer tube and the rolled appliance passes intothe oropharyngeal region. The retaining clip is then removed from theinner tube. The graspers may be used to facilitate repositioning of theappliance as necessary or desirable. The appliance is deployed byretraction of the outer tube. (The assembly/graspers may be used tolater remove the appliance if desired).

In a more specific, related embodiment of the invention, the followingmethod is provided. This method generally comprises the steps ofproviding a flat or pre-curved member (for example, appliance 110, 210,310, 410, 510, 610, 710, 810 910, 1010, 1110 or 1120 shown in thedrawings), pulling end portions of the flat or pre-curved membertogether to form a folded member and holding or temporarily securing theend portions together by means of a grasper, clamp, hemostat, suture(for example, a bioresorbable suture), and/or suitable means fortemporarily holding the end portions together in contact with oneanother. The method further comprises the steps of placing the member inthe folded or pinched configuration, into the oropharyngeal region, forexample by way of the oral or nasal cavity of the patient, and releasingthe end portions, thereby allowing the member to expand radially withinthe oropharyngeal region to provide a substantially constant radialforce against the lateral walls of the oropharyngeal region and/or thebase of the tongue.

The method may further comprise the step of repositioning the memberwhile the member is located within the oropharyngeal region and/or thestep of removing the member therefrom. This may be accomplished byfolding the member into a rolled or pinched configuration andwithdrawing the member from the body region.

Example 1

A 40-year-old, 5-foot, 11 in., 350 lb male is referred by his primarycare physician for evaluation of sleep disturbance. He experiencessnoring with apneic pauses, and severe daytime hypersomnolence withnarcolepsy, and has so for many years. His occupation as a truck driverhas been jeopardized by this behavior. Several years prior, he underwentuvulopalatoplasty (UPPP) and tonsillectomy, without any significantrelief of his symptoms. The patient claims that the use of CPAP wasattempted, but was unsuccessful.

A polysomnography is performed indicating a Respiratory DisturbanceIndex (RDI) of 113.4 with severe desaturations, bradycardia, andcomplete absence of stage 3, stage 4, and REM sleep. CPAP therapy wastitrated to 18, cm of water, but the patient's RDI remained elevated at60 with ongoing, severe desaturations.

Appliance 1400 having a length of about 70 mm and a width of about 1.0mm and a thickness of about 0.0075 inches (about 0.2 mm), is selected bythe physician for submucosal implantation.

Under general anesthesia, and using direct laryngoscopy techniques, theappliance is introduced into the submucosal tissues beginning in theright lateral pharyngeal region, particularly the right lateraloropharyngeal region. The appliance is introduced submucosally using acurved surgical needle which is used to carefully pull the applianceinto the tissues in a manner that causes the appliance to besubstantially concealed within the tissues, with little or no exposureof any portion of the appliance postsurgically.

The appliance is guided medially, and inferiorly, traveling around theposterior oropharyngeal region and ultimately into the submucosaltissues of the tongue base. The tongue base is then traversed and theappliance is brought back along the right lateral oropharyngeal wall.The appliance thus makes at least one complete rotation around thepharynx. Careful microscopic examination of the pharyngeal tissuesreveals no areas of appliance exposure. Extubation proceeds withoutdifficulty, and the patient is closely observed overnight.

During the first week of recovery, the patient reports having somedesire to cough out the device, throat pain, dysphagia, and hoarseness.

However, by the end of the first week, these symptoms are reported asminimal. Further, the patient indicates a significant reduction ineffort, wheezing, and noise during daytime breathing. A CT Scan isperformed to confirm adequate device placement and integrity. A modifiedbarium swallow study is obtained at the end of the second week. Thisstudy indicates that the appliance is intact, allowing normal swallowingin the pharyngeal region and appears to be providing circumferentialsupport to the oropharyngeal region.

Polysomnography is repeated at two weeks, showing significantimprovements in oxygen saturations and RDI.

Example 2

A 50 year old, 5 foot 4, 180 pound, female patient complains of severehypersomnolence. It is additionally noted that the patient's spouse haslong complained of the patient's substantial nightly snoring and haswitnessed pauses in the patient's breathing followed by gasping for airwhen she sleeps (believed to be apneic pauses).

Following clinical tests and evaluation of patient history, the patientis diagnosed with severe sleep apnea.

An appliance 1400 is selected for implantation in the patient. In thisexample, the appliance 1400 is made of Nitinol and has a length of about40 mm, a width of 1.25 mm and a thickness of about 0.5 mm.

Under general anesthesia, and using direct laryngoscopy techniques, theappliance is introduced into the submucosal tissues beginning in theright lateral oropharyngeal region. The appliance is then guidedmedially, and inferiorly, traveling around the posterior oropharyngealregion and ultimately into the submucosal tissues of the left lateraloropharynx. The appliance does not traverse the tongue. The appliancethus makes about a 180 degree rotation around the oropharynx.

Careful microscopic examination of the oropharyngeal tissues reveals noareas of appliance exposure. Extubation proceeds without difficulty, andthe patient is closely observed overnight.

Within two weeks, the patient reports feeling more energy during thedaytime and alertness upon awakening. Her husband remarks that thepatient's snoring has substantially decreased and she does not seem tobe experiencing apneic pauses during the night.

While this invention has been described with respect to various specificexamples and embodiments, it is to be understood that the invention isnot limited thereto and that it can be variously practiced within thescope of the following claims.

We claim:
 1. A method for treating obstructive sleep apnea of a patient,comprising: a) providing an arcuate support structure that is adaptedfor implant in an airway of the patient comprising a tongue movementresisting member; b) implanting the arcuate support member into thepatient's pharynx; and c) preventing the complete closure of the airwayby stopping the patient's tongue from complete collapse and blockage ofsubstantially all airflow, wherein the arcuate support structurecomprises first and second end portions, each of the first and secondend portions comprising a tongue movement resisting member, and whereinthe arcuate support structure comprises one or more protrusions locatedbetween the first and second end portions, and wherein the arcuatesupport structure is implanted into the pharynx such that the one ormore protrusions are disposed on a posterior wall of the pharynx.
 2. Themethod of claim 1, wherein the first and second end portions extendaround opposite lateral walls of the pharynx to support the tonguesufficiently to stop the tongue from complete collapse and blockage ofsubstantially all airflow.
 3. The method of claim 1, wherein the arcuatesupport structure extends around the pharynx such that the first andsecond end portions traverse a base of the tongue to stop the tonguefrom complete collapse and blockage of substantially all airflow.
 4. Themethod of claim 1, wherein the support structure is generally planar ina resting state, and wherein providing an arcuate support structurecomprises rolling or folding the support structure into an arcuateconfiguration before inserting the support structure into the pharynx.5. The method of claim 1, wherein the support structure is “C” shaped ina resting state, and wherein the providing an arcuate support structurestep comprises rolling or folding the arcuate support structure beforeinserting the support structure into the pharynx.
 6. A method fortreating obstructive sleep apnea of a patient, comprising: a) providingan arcuate support structure defining a lumen comprising one or moreflexible members; and b) implanting the arcuate support structure intothe patient's pharynx, c) the one or more flexible members flex allowingadjacent tissue or organs to encroach on the lumen of the arcuatesupport structure while preventing complete closure of the patient'sairway while allowing the patient's tongue to contact a wall of thepharynx, wherein the one or more flexible members comprise first andsecond end portions of the arcuate support structure, and wherein thearcuate support structure comprises one or more protrusions locatedbetween the first and second end portions, and wherein the arcuatesupport structure is implanted into the pharynx such that the one ormore protrusions are disposed on a posterior wall of the pharynx.
 7. Themethod of claim 6, wherein the first and second end portions extendaround opposite lateral walls of the pharynx to support the tonguesufficiently to prevent the complete closure of the airway.
 8. Themethod of claim 6, wherein the arcuate support structure extends aroundthe pharynx such that the first and second end portions traverse a baseof the tongue to prevent complete closure of the airway.
 9. The methodof claim 6, wherein the one or more flexible members are sufficientlyflexible such that, upon contraction of the pharynx during swallowing,the one or more flexible members are temporarily forced toward oneanother.